biote Corp. (BTMD) Key Metrics
BTMD valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $36.8M
- Enterprise value
- $154.8M
- P/E (TTM)
- 7.8 10-yr median 20.9
- Forward P/E
- 5.2
- PEG ratio
- —
- Price / sales
- 0.2 10-yr median 0.5
- Price / book
- 3.0
- EV / EBITDA
- 6.6 10-yr median 3.7
- Dividend yield
- —
- Beta
- 1.69
BTMD key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBTMD valuation Price multiples at each fiscal year-end price.
BTMD returns How much profit the business earns on the capital it uses.
BTMD per-share figures Results divided by the shares outstanding at year-end.
BTMD financial health Debt, liquidity and how easily interest is covered.
BTMD efficiency & capital use Working capital cycle and where the cash goes.
BTMD valuation history
BTMD returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BTMD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BTMD cash returned to shareholders
BTMD price vs earnings per share
BTMD key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $95.3M | $211.8M | $127.0M | $30.1M | $74.2M | — | — |
| Enterprise value | $181.1M | $283.3M | $152.9M | $71.3M | $84.8M | — | — |
| P/E ratio | 3.5 | 67.1 | 38.3 | — | 2.3 | — | — |
| Price / sales | 0.5 | 1.1 | 0.7 | 0.2 | 0.5 | — | — |
| Price / book | — | — | — | — | 18.0 | — | — |
| Price / free cash flow | 3.2 | 5.5 | 5.3 | — | 2.5 | — | — |
| Price / operating cash flow | 2.7 | 4.7 | 4.7 | — | 2.2 | — | — |
| EV / sales | 0.9 | 1.4 | 0.8 | 0.4 | 0.6 | — | — |
| EV / EBITDA | 3.5 | 18.2 | 3.7 | 9.0 | 2.4 | — | — |
| EV / free cash flow | 6.0 | 7.3 | 6.3 | — | 2.8 | — | — |
| Earnings yield | 28.4% | 1.5% | 2.6% | −3.2% | 43.9% | — | — |
| Free cash flow yield | 31.7% | 18.3% | 19.0% | −36.6% | 40.3% | — | — |
| Dividend yield | 1.8% | 2.2% | 6.8% | 42.9% | 15.4% | — | — |
| Shareholder yield (dividends + buybacks) | 5.3% | 4.9% | 6.8% | 44.3% | 15.4% | — | — |
| Share price at fiscal year-end | $2.60 | $6.18 | $4.94 | $3.73 | $9.80 | — | — |
| Per share | |||||||
| Revenue per share | $5.24 | $5.75 | $7.21 | $20.47 | $18.40 | $15.39 | $14.52 |
| Earnings per share | $0.74 | $0.09 | $0.13 | −$0.12 | $4.31 | $3.85 | $2.81 |
| Operating cash flow per share | $0.96 | $1.32 | $1.05 | −$1.14 | $4.45 | $3.49 | $3.35 |
| Free cash flow per share | $0.82 | $1.13 | $0.94 | −$1.36 | $3.95 | $3.30 | $3.13 |
| Cash per share | $0.66 | $1.15 | $3.46 | $9.83 | $3.53 | $2.27 | $1.38 |
| Book value per share | −$1.60 | −$3.09 | −$1.14 | −$5.52 | $0.54 | −$2.25 | −$4.35 |
| Tangible book value per share | −$1.87 | −$3.53 | −$1.34 | −$6.15 | −$0.06 | −$2.60 | −$4.59 |
| Dividends per share | $0.05 | $0.14 | $0.34 | $1.60 | $1.51 | $1.76 | $7.48 |
| Capex per share | $0.14 | $0.19 | $0.11 | $0.23 | $0.50 | $0.18 | $0.22 |
| Debt per share | $3.00 | $3.23 | $4.47 | $14.94 | $4.93 | $5.59 | $6.22 |
| Shares outstanding | 36.7M | 34.3M | 25.7M | 8.1M | 7.6M | 7.6M | 7.6M |
| Change in shares outstanding | +7.0% | +33.3% | +219.0% | +6.4% | 0.0% | 0.0% | — |
| Returns & profitability | |||||||
| Return on invested capital (ROIC) | — | — | — | — | 300.9% | 535.6% | 629.9% |
| Return on assets (ROA) | 23.5% | 2.3% | 2.5% | −1.2% | 75.1% | 103.3% | 89.1% |
| Return on tangible assets | 27.7% | 2.9% | 2.2% | −0.9% | 65.5% | 97.2% | 96.5% |
| Free cash flow margin | 15.7% | 19.7% | 13.0% | −6.7% | 21.5% | 21.5% | 21.5% |
| Income quality (OCF / net income) | 1.30 | 14.33 | 8.11 | — | 1.03 | 0.91 | 1.19 |
| Financial health | |||||||
| Total debt | $109.9M | $110.9M | $114.9M | $120.4M | $37.3M | $42.4M | $47.1M |
| Cash & short-term investments | $24.1M | $39.3M | $89.0M | $79.2M | $26.8M | $17.2M | $10.5M |
| Net debt | $85.8M | $71.5M | $25.9M | $41.2M | $10.6M | $25.1M | $36.6M |
| Debt / equity | — | — | — | — | 9.05 | — | — |
| Debt / assets | 1.02 | 0.91 | 0.74 | 1.08 | 0.69 | 1.30 | 1.97 |
| Net debt / EBITDA | 1.64 | 4.59 | 0.62 | 5.18 | 0.29 | 0.76 | 1.51 |
| Current ratio | 1.22 | 1.32 | 5.51 | 5.39 | 2.72 | 2.38 | 1.43 |
| Quick ratio | 0.79 | 1.03 | 4.73 | 4.80 | 2.16 | 2.01 | 1.14 |
| Interest coverage | 3.2 | 2.9 | 4.5 | -15.0 | 20.7 | 13.1 | 11.3 |
| Working capital | $9.7M | $16.6M | $100.1M | $82.4M | $29.8M | $16.1M | $5.8M |
| Invested capital | $27.3M | −$34.4M | −$3.5M | −$3.3M | $14.7M | $8.1M | $3.7M |
| Tangible asset value | −$60.5M | −$117.4M | −$41.5M | −$63.3M | −$429,000 | −$19.7M | −$34.8M |
| Net current asset value | −$103.3M | −$156.4M | −$69.5M | −$68.7M | −$3.1M | −$21.8M | −$37.5M |
| Graham number | — | — | — | — | $7.26 | — | — |
| Graham net-net per share | −$3.23 | −$5.02 | −$3.43 | −$9.91 | −$1.94 | −$3.53 | −$5.46 |
| Capital allocation | |||||||
| Dividends paid | $1.7M | $4.7M | $8.7M | $12.9M | $11.4M | $13.3M | $56.6M |
| Share buybacks (net) | $3.4M | $5.6M | $0 | $424,000 | $0 | — | — |
| Dividend payout ratio | 6.4% | 150.3% | 262.2% | — | 35.0% | 45.7% | 266.0% |
| Dividends + buybacks / free cash flow | 16.9% | 26.6% | 36.0% | — | 38.1% | 53.2% | 239.1% |
| Capex / revenue | 2.6% | 3.3% | 1.5% | 1.1% | 2.7% | 1.2% | 1.5% |
| Capex / operating cash flow | 14.2% | 14.2% | 10.1% | — | 11.3% | 5.3% | 6.6% |
| Capex / depreciation | 1.37 | 1.80 | 0.91 | 0.84 | 2.72 | 1.22 | 2.01 |
| Stock-based compensation / revenue | 4.6% | 4.4% | 4.9% | 49.8% | 0.0% | — | — |
| SG&A / revenue | 53.0% | 54.5% | 50.4% | 103.7% | 38.7% | 32.1% | 35.7% |
| Efficiency | |||||||
| Days sales outstanding | 14.6 | 14.7 | 14.9 | 13.5 | 13.0 | 13.7 | 13.3 |
| Days of inventory on hand | 112.8 | 100.9 | 89.8 | 69.5 | 52.1 | 33.5 | 32.8 |
| Days payables outstanding | 42.0 | 31.3 | 26.1 | 28.3 | 25.4 | 22.9 | 26.7 |
| Cash conversion cycle (days) | 85.4 | 84.3 | 78.7 | 54.7 | 39.7 | 24.3 | 19.4 |
| Receivables turnover | 25.00 | 24.84 | 24.52 | 27.09 | 28.02 | 26.69 | 27.38 |
| Payables turnover | 8.68 | 11.66 | 14.00 | 12.90 | 14.37 | 15.95 | 13.66 |
| Inventory turnover | 3.24 | 3.62 | 4.06 | 5.25 | 7.00 | 10.90 | 11.12 |
| Asset turnover | 1.67 | 1.42 | 1.39 | 1.99 | 3.21 | 4.13 | 4.60 |
| Average receivables | $7.7M | $7.9M | $7.6M | $6.1M | $5.0M | $4.4M | $4.0M |
| Average payables | $6.3M | $5.0M | $4.1M | $4.2M | $3.4M | $2.8M | $3.2M |
| Average inventory | $17.0M | $16.1M | $14.2M | $10.4M | $7.0M | $4.1M | $3.9M |
| Intangibles / total assets | 9.4% | 12.4% | 3.2% | 4.5% | 8.4% | 8.0% | 7.6% |
Computed from BTMD's annual financial statements (latest annual report filed March 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BTMD valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), biote traded at 3.5 times earnings, against a 7-year median of 20.9. Based on the latest twelve months, the trailing P/E is 7.8 and the forward P/E is 5.2. It ended the year with $109.9 million of debt and $24.1 million in cash and short-term investments, net debt of $85.8 million. It returned $5.1 million to shareholders: $1.7 million in dividends and $3.4 million in share buybacks, 17% of free cash flow. The share count rose 384.1% from 7.6M to 36.7M over 6 years.
See the BTMD income statement, the BTMD chart for price history, or the BTMD stock overview for the latest quote and news.
BTMD key metrics FAQ
What is biote's P/E ratio?
biote's trailing P/E ratio is 7.8 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 5.2. At the end of fiscal 2025 it was 3.5, compared with a 7-year median of 20.9.
What is biote's EV/EBITDA?
biote's enterprise value was 3.5 times EBITDA at the end of fiscal 2025 (enterprise value $181.1 million, EBITDA $52.2 million); the current EV/EBITDA is 6.6.
How much debt does biote have?
biote had total debt of $109.9 million at the end of fiscal 2025 and $85.8 million of net debt (1.64 times EBITDA).
What is biote's dividend yield?
biote paid $1.7 million in dividends in fiscal 2025 ($0.05 per share), a payout ratio of 6.4%.
Does biote buy back its shares?
Yes. biote spent $3.4 million on net share repurchases in fiscal 2025 Shares outstanding changed +7.0% over the year, to 36.7M..
What is biote's free cash flow yield?
biote generated $30.2 million of free cash flow in fiscal 2025, a free cash flow yield of 31.7% on its market value at year-end ($95.3 million).
What is biote's current ratio?
biote's current ratio was 1.22 at the end of fiscal 2025: current assets were 1.22 times current liabilities.